Every time a cell divides, it must copy its entire genome so that each daughter cell inherits a complete set of DNA. During ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...

Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct . The study, which was conducted by ...

A new AI model by Google DeepMind can decipher DNA and predict mutations, opening new doors for disease research. View on ...

Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic diagnostic test designed to inform surgical decision ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

According to the Health Ministry, cervical cancer accounts for 16.3 percent of cancer cases in Indonesia, with a mortality ...

Class A shares of the Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index during the fourth quarter of 2025 ...

In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks associated with exposure. In ...